Royal Bank Of Canada Instil Bio, Inc. Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.4 - $0.63 $0 - $0	1 Added 5.56%	19 $0
Q2 2023 Aug 14, 2023	SELL	$0.51 - $0.67 $1,983 - $2,606	-3,890 Reduced 99.54%	18 $0
Q1 2023 May 15, 2023	SELL	$0.6 - $0.91 $3,543 - $5,374	-5,906 Reduced 60.18%	3,908 $2,000
Q4 2022 Feb 14, 2023	BUY	$0.48 - $5.33 $4,302 - $47,778	8,964 Added 1054.59%	9,814 $6,000
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.37 $2,129 - $3,375	458 Added 116.84%	850 $4,000
Q2 2022 Aug 15, 2022	SELL	$4.21 - $11.15 $12,335 - $32,669	-2,930 Reduced 88.2%	392 $2,000
Q1 2022 May 16, 2022	SELL	$8.48 - $18.1 $57,104 - $121,885	-6,734 Reduced 66.96%	3,322 $36,000
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $120,838 - $176,895	7,862 Added 358.34%	10,056 $172,000
Q3 2021 Nov 15, 2021	SELL	$15.05 - $23.28 $2,994 - $4,632	-199 Reduced 8.32%	2,194 $40,000
Q2 2021 Aug 16, 2021	BUY	$15.31 - $24.63 $36,636 - $58,939	2,393 New	2,393 $46,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.